参考文献/References:
[1] van Bilsen M, Smeets PJ, Gilde AJ, et al. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?[J].Cardiovasc Res,2004,61(2):218-226.
[2] Ventura-Clapier R, Garnier A, Veksler V, et al. Bioenergetics of the failing heart[J]. Biochim Biophys Acta,2011,1813:1360-1372.
[3] Dorn GW.Mitochondrial dynamics in heart disease[J].Biochim Biophys Acta, 2013,1833:233-241.
[4] Ong SB, Hall AR, Hausenloy DJ. Mitochondrial dynamics in cardiovascular health and disease[J]. Antioxid Redox Signal,2013,19:400-414.
[5] Chen Y, Wang Y, Chen J, et al. Roles of transcriptional corepressor RIP140 and coactivator PGC-1alpha in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes[J]. Mol Cell Endocrinol,2012,362:11-18.
[6] Song R,Zhu SJ,Zhang HM, et al. ATPase may play a critical role in disturbance of energy metabolism in congestive heart failure rats[J].Int J Clin Exp Med, 2014,7(10):3654-3658.
[7] Guzman MG,Baez A,Cordoba R,et al.Role of mitochondria and reactive oxygen species in the progression of heart failure[J].Rev Fac Cien Med Univ Nac Cordoba,2010,67(4):150-158.
[8] Gzman MG,Baez A,Cordoba R,et al.Role of mitochondria and reactive oxygen species in the progression of heart failure[J].Rev Fac Cien Med Univ Nac Cordoba,2010,67(4):150-158.
[9] Unno K,Isobe S,Izawa H,et al.Relation of functional and morphological changes in mitochondria to mildly symptomatic patients with hypertropic cardiomyopathy[J].Eur Heart J,2009,30(15):1853-1862.
[10] Schulz TJ,Westermann D,Isken F,et al. Activation of mitochondrial energy metabolism protects against cardiac failure[J].Aging(Albany NY),2010,2(11):843-853.
[11] Maack C, Bohm M.Targeting mitochondrial oxidative stress in heart failure throttling the afterburner[J]. J Am Coll Cardiol,2011,58:83-86.
[12] Pohjoismäki JL, Boettger T, Liu Z,et al.Oxidative stress during mitochondrial biogenesis compromises mtDNA integrity in growing hearts and induces a global DNA repair response[J]. Nucl Acids Res,2012,40:6595-6607.
[13] Chandran K, Aggarwal D, Migrino RQ, et al. Doxorubicin inactivates myocardial cytochrome C oxidase in rats:cardioprotection by Mito-Q[J]. Biophys J,2009,96(4): 1388-1398.
[14] Dai DF, Chen T, Szeto H, et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy[J].J Am Coll Cardiol,2011,58:73-82.
[15] Sten O, Vladimir G, Boris Z.Calcium and mitochondria in the regulation of cell death[J].Biochem Biophys Res Commun,2015,460:72-81.
[16] Mejia EM,Cole LK,Hatch GM,et al.Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation[J].Cardiovasc Haematol Disorders Drug Targets,2014,14:98-106.
[17] Naiel A, Barak Z,Fuad F,et al. Endothelial nitric oxide synthase polymorphism and prognosis in systolic heart failure patients[J].Nitric Oxide,2015,47:91-96.
[18] Khairallah RJ, O'shea KM, Brown BH,et al. Treatment with docosahexaenoic acid, but not eicosapentaenoic acid, delays Ca2+-induced mitochondria permeability transition in normal and hypertrophied myocardium[J].Pharmacol Exp Ther,2010,335:155-162.
[19] 林立. 果糖激酶和脂联素对心力衰竭心脏能量代谢的影响[J].心血管病学进展,2010, 31(4):99-602.
[20] Murray AJ, ColeMA, Lygate CA, et al. Increased mitochondrial uncoupling proteins,respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart[J].Mol Cell Cardiol,2008,44:694-700.
[21] Wang D,Liu B,Tao W,et al.Fibrates for secondary prevention of cardiovascular disease and stroke[J]. Cochrane Database Syst Rev,2015,10:CD009580.
[22] Loiacono F,Alberti L,Lauretta L,et al.Metabolic therapy for heart failure [J].Recenti Prog Med,2014,105(7):288-294.
[23] Stefan G,Micha M.The effect of trimetazidine added to pharmacological treatment on all-cause mortality in patients with systolic heart failure[J].Cardiology,2015,131(1):22-29.
[24] Lu Z, Xu X,Hu X, et al. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload[J]. Antioxid Redox Signal,2010,13:1011-1022.
[25] 吴泓权,刘地川,童欣,等.超声微泡介导MCD-microRNA干扰质粒对大鼠心肌梗死后心功能的影响[J].解放军医学杂志,2012,37(5):400-404.
相似文献/References:
[1]陈忠秀,综述,饶莉,等.线粒体能量代谢异常与病理性心肌肥大的研究进展[J].心血管病学进展,2016,(3):247.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.008]
CHEN Zhongxiu,RAO Li.Mitochondrial Energy Metabolism and Pathological Cardiac Hypertrophy[J].Advances in Cardiovascular Diseases,2016,(1):247.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.008]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(1):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(1):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(1):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(1):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]公雪,综述,李晓燕,等.力竭运动对心肌组织结构及功能影响的研究进展[J].心血管病学进展,2016,(4):435.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.028]
GONG Xue,LI Xiaoyan.Research Progress of Effect of Exhaustive Exercise on Structure
and Function of Cardiac Muscle[J].Advances in Cardiovascular Diseases,2016,(1):435.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.028]
[7]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(1):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[8]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[9]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(1):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[10]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]